Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1995-06-02
1999-12-21
Kunz, Gary L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536 276, A61K 3170, C07H 1967
Patent
active
060049456
ABSTRACT:
A method of inducing anesthesia, sedation, analgesia, hypothermia, and reduced stress by administering an effective amount of an adenosine compound to a mammal. It also provides a method for preserving donor organs in vivo by contacting them with an adenosine compound, as well as a method for preparing organ recipients for transplant.
REFERENCES:
patent: 4605644 (1986-08-01), Foker
patent: 4673563 (1987-06-01), Berne et al.
patent: 4755594 (1988-07-01), Bridges et al.
patent: 4880783 (1989-11-01), Mentzer, Jr. et al.
patent: 4880918 (1989-11-01), Rapaport
patent: 5049372 (1991-09-01), Rapaport
patent: 5104859 (1992-04-01), Sollevi
patent: 5691318 (1997-11-01), Sollevi
Fredholm et al., "The Release of Adenosine and Inosine from Canine Subcutaneous Adipose Tissue by Nerve Stimulation and Noradrenaline," J. Physiology (G. Britain), 313, 351-367 (1981); only pp. 351-362 supplied--complete copy on order.
Carson et al. (I), "Specific Toxicity of 2-Chlorodeoxyadenosine Toward Resting and Proliferating Human Lymphocytes," Blood, 62(4), 737-743 (Oct. 1983).
Carson e al. (II), "Possible Metabolic Basis for the Different Immunodeficient States Associates with Genetic Deficiencies of Adenosine Deaminase and Purine Nucleoside Phosphorylase," Proc. Nat. Acad. Sci. USA, 79, 3848-3852 (Jun. 1982).
Carson et al. (III), "Deoxycytidne Kinas-mediated Toxicity of Deoxyadenosine Analogs Toward Malignant Human Lymphoblasts In vitro and Toward Murine L1210 Leukemia In vivo," Proc. Natl. Acad. Sci. USA, 77(11), 6865-6869 (Nov. 1980).
Woolf (I), "Recent Advances in the Pathophysiology of Acute Pain," British journal of Anesthesia, 63, 139-146 (1989).
Woolf (II), "Evidence for a Central Component of Post-Injury Pain Hypersensitivity," Nature, 306(15), 686-688 (Dec. 15, 1983).
Mitchell et al., "The Control of Acute Postoperative Pain," British Journal of Anesthesia, 63, 147-158 (1989).
Forman et al., "Adenosine Attenuates Reperfusion Injury Following Regional Myocardial Ischemia," Cardiovascular Research, 27, 9-17 (1993).
Bonica, "Definitions and Taxonomy of Pain," Ch. 2 in vol. I of The Management of Pain, 2nd Edition, Lea & Febiger, Philadelphia, PA, 1990, only pp. 18-27 supplied.
Bonica, "Postoperative Pain," Ch. 25 in vol. I of The Management of Pain, 2nd Edition, Lea & Febiger, Philadelphia, PA, 1990, only pp. 461-480 supplied.
Burnstock, "Overview--Purinergic Mechanisms," see Part I of "Biological Effects of Extracellular ATP and Nucleotides" in "Biological Actions of Extracellular ATP," Dubyak et al. (eds.), Annals of the New York Academy of Sciences, 603, 1-17 (1990).
Moser et al., "Turnover of Adenosine in Plasma of Human and Dog Blood," American journal of Physiology (Cell Physiology 25), 256, C799-C806 (1989).
Dedrick et al., "Does ATP-Induced Hypotension Cause Potentially Serious Metabolic Complications?" Anesthesiology, 57(3), A66 (Sep. 1982).
Belfrage, Sollevi, et al., "Systemic Adenosine Infusion Alleviates Spontaneous and Stimulus Evoked Pain in Patients with Peripheral Neuropathic Pain," Anesthesia & Analgesia, 81, 713-717 (1995).
Segerdahl, Sollevi, et al., "Peroperative Adenosine Infusion Reduces the Requirements for Isoflurane and Postoperative Analgesics," Anesthesia & Analgesia, 80,m 1145-1149 (1995).
Fukunaga et al.(I), "ATP Induced Hypotensive Anesthesia During Surgery," Anesthesiology, 57, A65 (1982).
Fukunaga et al.(II), "Hyptotensive Effects of Adenosine and Adenosine Triphosphate Compared with Sodium Nitroprusside," Anesthesiology, 61(3), 273-278 (1982).
Dunwiddie et al., "Sedative and Anticonvulsive Effects of Adenosine Analogs in Mouse and Rat," J. Pharm. and Expert Therapeutics, 220, 70-76 (1982).
Seitz et al., "Adenosine Reduces Halothane MAC in Dogs," Anesthesiology, 68, A263 (1989).
Homeister et al., "Combined Adenosine and Lidocaine Administration Limits Myocardial Reperfusion Injury," Circulation, 82(2), 595-608 (1990).
Gomaa, "Characteristics of Analgesia Induced by Adenosine Triphosphate," Pharmacology and Toxicology, 61, 199-202 (1987).
Drury et al., "The Physiological Activity of Adenine Compounds with Especial Reference to Their Action Upon the Mammalian Heart," J. Physiology(Cambridge, England), 68, 213-237 (1929).
Birch et al.(I), "L-Phenylisopropyladenosine (L-PIA) Diminishes Halothane Anesthetic Requirements and Decreases Noradrenergic Neurotransmission in Rats," Life Sciences, 42, 1355-1360 (1988).
Vapaatalo et al., "Stereospecificity in Some Central and Circulatory Effects of Phenylisopropyladenosine (PIA)," Arzneim. Forsch. (Drug Res.), 25(3), 407-410(1975).
Phillis et al.(I), "Roles of Adenosine and Adenine Nucleotides in the Central Nervous System," in Physiology and Pharmacology of Adenosine Derivatives,Daly et al. eds., Raven Press, New York, 1983, pp. 219-235.
Phillis et al.(II), "Evidence for an A.sub.2 -like Receptor on Cerebral Cortical Neurons," J. Pharm. Pharmacol., 34, 453-454 (1982).
Nunn et al., "Introduction," in General Anesthesia, 5th Ed., Nunn et al. eds., Butterworth, London, 1989, pp. 1-6.
Ohisalo et al., "Regulatory Functions of Adenosine," Medical Biology, 65, 181-191 (1987).
Williams (I), "Tissue and Species Differences in Adenosine Receptors and Their Possible Relevance to Drug Development," in Adenosine: Receptors and Modulation of Cell Function, Stefanovich et al. (eds.), IRL Press Ltd., Oxford, UK, 1985, pp. 73-84.
Stoelting et al. (eds.), Principles of Anesthesia, 2nd Ed., Churchill Livingstone, New York, NY, 1989, pp. 115-119.
Katzung (ed.), Basic & Clinical Pharmacology, Ch. 24, Appleton & Lange, Norwalk, Connecticut, 1995, pp. 381-394.
Seitz et al., "Adenosine Decreases the Minimum Aveolar Concentration of Halothane in Dogs," Anesthesiology, 73, 990-994 (1990).
Orwall et al., "Clinical Experience with Adenosine for Controlled Hypotension During Cerebral Aneurysm Surgery," Anesthesiology and Analgesia, 66, 229-234 (1987).
Williams (II), "Purine Receptors in Mammalian Tissues: Pharmacology and Functional Significance," Ann. Rev. Pharmacology & Toxicology, 27, 315-345 (1987); see particularly pp. 316, 328-329 and 335 refer to "hypnotic effects.".
Haulica et al., "Preliminary Data on the Possible Hypnogenic Role of Adenosine," J. Neurochem., 21, 10-19-1020 (1973).
Birch et al.(II), "L-phenylisopropyladenosine (L-PIA) Diminishes Halothane Anesthetic Requirements and Decreases Neurotransmission in Rats," Life Science, 42(14), 1355-1360 (1988); p. 1355, second paragraph, lines 5-7.
Conradson et al., "Cardiovascular Effects of Infused Adenosine: Potentiation by Dipyridamole," 129, 387-391 (1987).
Eger et al., "Minimum Aveolar Anesthetic Concentration [MAC]: A Standard of Anesthetic Potency," Anesthesiology, 26, 756-763 (1965).
Synder, "Adenosine as Neuromodulator," Ann. Rev. Neuroscience, 8, 103-124 (1985); see pp. 108 & 119, second paragraphs.
Bloor et al.(I), "Reduction of Halothane Anesthetic Requirement by Clonidine, an Alpha-Adrenergic Agonist," Anesthesia and Analgesia, 61, 741-745 (1982).
Maze et al., "Anesthetic and Hemodynamic Effects of the Alpha2-Adrenergic Agonist, Azepexole, in Isoflurane-Anesthetized Dogs," Anesthesiology, 68(5), 689-694 (1988).
Segal et al., "Dexmedetomidine Dimishes Halothane Anesthetic Requirements in Rats Through a Post Synaptic Alpha.sub.2 Adrenergic Receptor," Anesthesiology, 68(6), 818-823 (1988); see particularly col. 2 of p. 818, last paragraph.
Tanifuji et al., "Effect of Arterial Hypotension on Anesthetic Requirements in Dogs," British J. Anesthesiology, 48(10), 947-951 (1976).
Dunwiddie, "The Physiological Role of Adenosine in the Central Nervous System," International Reviews in Neurobiology, 27, 63-139 (1985); see particularly pp. 95-99, 121 and 126-128.
Feldberg et al., "Injection of Drugs into the Left Ventricle of the Cat," J. Physiology London, 123, 148-167 (1954).
Radulovacki et al., "Hypnotic Effects of Deoxycoformycin in Rats," Brain Research, 27, 271, 392-395 (1983).
Jonzon et al., "Modulation of Neurotransmission by Purine Nucleosides and Nucleotides," Life Science, 1984, 1971-1979.
Galloway et al., "Clonidine Prevents Methylxanthine Stimulation of NE Metabolism in Rats," J. Neuroc
Kunz Gary L.
Schein, Esq. Daniel B.
LandOfFree
Use of adenosine compounds to relieve pain does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of adenosine compounds to relieve pain, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of adenosine compounds to relieve pain will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-505238